Additionally, a proteomics screen of inflammation-associated proteins showed several differences between Risk-RA and healthy controls, and some differences between the arthritis progressors and non-progressors, with notably slightly higher serum IL-6 levels and lower IL-15Rα levels in the group of progressors. The gene discussed is IL6; the disease is arthritic joint disease.